3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
13
Gastrointestinal Stromal Tumors
12
Leukemia, Myeloid, Chronic-Phase
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
3
Neoplasms
2
Melanoma
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
1
Philadelphia Chromosome
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Lymphangioleiomyomatosis
1
Leukemia, Myeloid
1
Leukemia, Biphenotypic, Acute
1
Hypereosinophilic Syndrome
1
Hematologic Diseases
1
Head and Neck Neoplasms
1
Graft vs Host Disease
1
Digestive System Neoplasms
1
Desmoid Tumors
1
Dermatofibrosarcoma
1
Congenital Bone Marrow Failure Syndromes
1
Chordoma
1
Carcinoma, Adenoid Cystic
1
Interventions
Cytarabine
3
Injections
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Decitabine
2
veliparib
1
fludarabine phosphate
1
aldesleukin
1
Whole-Body Irradiation
1
Temozolomide
1
Peripheral Blood Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Etoposide
1
Daunorubicin
1
CPX-351
1
Busulfan
1
Bone Marrow Transplantation
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Acute
×
Imatinib Mesylate
×
1 year
×
Clear all
No trials found.